Skinvisible (SKVI) Profit After Tax (2010 - 2026)
Skinvisible's (SKVI) quarterly Profit After Tax came in at -$255533.0 in Q2 2026, up 6.88% year-over-year from -$239073.1 in Q2 2025, and up 4.36% quarter-over-quarter from -$267184.0 in Q1 2026.
Powered by 
Analysis
Skinvisible (SKVI) Profit After Tax (2010 - 2026) Analysis & Trends
Skinvisible has disclosed Profit After Tax across 17 years of filings, most recently posting -$255533.0 for Q2 2026.
- In Q2 2026, Profit After Tax rose 6.88% year-over-year to -$255533.0; the TTM figure through Jun 2026 stood at -$1.0 million (down 95.6% YoY), while the FY2025 annual figure was -$1.1 million, down 88.11% from the prior year.
- Profit After Tax came in at -$255533.0 for Q2 2026 at Skinvisible, up from -$267184.0 in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of $314771.0 in Q4 2024 to a low of -$1.5 million in Q1 2023.
- Average Profit After Tax over 5 years is -$319985.1, with a median of -$278540.0 recorded in 2023.
- Year-over-year, Profit After Tax tumbled 606.26% in 2023 and surged 203.61% in 2024.
- Over 5 years, Profit After Tax stood at -$400577.0 in 2022, then climbed by 24.16% to -$303791.0 in 2023, then surged by 203.61% to $314771.0 in 2024, then sank by 182.08% to -$258357.0 in 2025, then rose by 1.09% to -$255533.0 in 2026.
- Per Business Quant data, the three most recent Profit After Tax figures were -$255533.0 in Q2 2026, -$267184.0 in Q1 2026, and -$258357.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 647.22 Bn | 626.46 Bn | 17.26 Bn | 5.53 Bn |
| 2 | AbbVie | 440.28 Bn | 433.71 Bn | 12.70 Bn | 3.62 Bn |
| 3 | Merck | 364.30 Bn | 357.16 Bn | 12.21 Bn | -1.34 Bn |
| 4 | Novartis Ag | 268.44 Bn | 260.75 Bn | 11.24 Bn | 3.26 Bn |
| 5 | Pfizer | 158.60 Bn | 146.90 Bn | 10.94 Bn | -248.00 Mn |
| 6 | Sanofi | 52.56 Bn | 45.18 Bn | 10.79 Bn | 438.21 Mn |
| 7 | Revolution Medicines | 44.31 Bn | 44.31 Bn | - | -644.37 Mn |
| 8 | Incyte | 24.98 Bn | 20.45 Bn | 1.57 Bn | 585.61 Mn |
| 9 | United Therapeutics | 21.16 Bn | 18.49 Bn | 683.80 Mn | 333.00 Mn |
| 10 | Skinvisible | 1.08 Mn | 1.08 Mn | 5,000.00 | -255,533.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -255,533.00 |
| Mar 31, 2026 | -267,184.00 |
| Dec 31, 2025 | -258,357.00 |
| Sep 30, 2025 | -250,245.00 |
| Jun 30, 2025 | -274,427.00 |
| Mar 31, 2025 | -281,005.00 |
| Dec 31, 2024 | 314,771.00 |
| Sep 30, 2024 | -286,604.00 |
| Jun 30, 2024 | -303,449.00 |
| Mar 31, 2024 | -290,372.00 |
| Dec 31, 2023 | -303,791.00 |
| Sep 30, 2023 | -287,518.00 |
| Jun 30, 2023 | -276,075.00 |
| Mar 31, 2023 | -1.52 Mn |
| Dec 31, 2022 | -400,577.00 |
| Sep 30, 2022 | -418,068.00 |
| Jun 30, 2022 | -191,723.00 |
| Mar 31, 2022 | -214,519.00 |
| Dec 31, 2021 | -165,382.00 |
| Sep 30, 2021 | -203,352.00 |